ATU DC’s Rend Al-Mondhiry, Katie Bond, and Ivan Wasserman have been featured in a recent article published by Natural Products Insider assessing the potential issues with dietary supplement advertising by the new FTC leadership under the Republican Administration. To read the full article, please click HERE.
Shashank Upadhye will be speaking at ACI’s 12th Annual Paragraph IV Disputes conference in New York on April 23, 2018. The Paragraph IV conference is one of the biggest and most important conferences in the brand-generic drug industry. Learn more and attend the conference HERE.
Shashank Upadhye will be giving an Insight Briefing at the CPHI North America conference in Philadelphia on Tuesday, April 24, 2018. He will speak about IP/patent issues facing API and FDF companies, how to create defensible legal strategies, reduce costs, and improve licensing abilities. Learn more about the CPHI event HERE.
Shashank Upadhye spoke at the 7th pharma IP summit in Mumbai in March 2018. He gave two different talks. The first was about how to manage legal/litigation costs by speaking about best practices that both law firms and clients can implement to reduce costs. Because of his long in-house experience, he spoke about cost controls […]
New Hope Network recently featured an article published by Rend Al-Mondhiry titled, “8 Things I Learned from 8 Years as a Dietary Supplement Trade Association Attorney”. Al-Mondhiry not only shares her wisdom from her time serving as counsel for two of the leading trade associations in the dietary supplement industry, but also provides useful advice to attorneys […]
ATU is looking forward to Expo West 2018 in Anaheim, CA! Ivan Wasserman, Ashish Talati, and Rakesh Amin will be attending from March 7-11 and would love to meet up. They are looking forward to checking out the show floor, reconnecting with some of the firm’s favorite brands, and discovering new ones! If you would […]
In February 2018, Joe Cwik spoke at the 2018 GOED Exchange conference in Seattle concerning the International Trade Commission (ITC) litigation filed by Amarin Pharma, Inc. Joe Cwik and others earned a ground breaking win in that litigation when the ITC dismissed the false advertising suit finding that the Complaint failed to allege an unfair […]
Leading regulatory and intellectual property law firm Amin Talati today announced that effective June 1, 2019, the firm’s name changed to Amin Talati Wasserman LLP, making Ivan Wasserman, who also serves as the firm’s managing MORE >
The content in the Amin Talati Wasserman web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Talati Wasserman or as the rendering of legal advice for any specific matter.